Steroids for idiopathic sudden sensorineural hearing loss

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 7, 2013, Pages

  Wei, Benjamin P C ^a   Stathopoulos, Dimitra ^a   O'Leary, Stephen ^a  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PLACEBO; PREDNISOLONE; STEROID; ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; METHYLPREDNISOLONE;

FOLLOW UP; HEARING; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS; META ANALYSIS; OUTCOME ASSESSMENT; PERCEPTION DEAFNESS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SPEECH; SUDDEN DEAFNESS; SYSTEMATIC REVIEW; TINNITUS; TREATMENT DURATION; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; GLUCOCORTICOIDS; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; METHYLPREDNISOLONE; PREDNISOLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891645357     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003998.pub3     Document Type: Review

References (130)

1. Cinamon U, Bendet E, Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. European Archives of Oto-Rhino-Laryngology 2001;258(9):477-80.
2. Nosrati-Zarenoe R. Idiopathic Sudden Sensorineural Hearing Loss. Corticosteroid Treatment, the Diagnostic Protocol and Outcome. Linköping University medical dissertation No. 1229. Linköping, Sweden: Linköping University, 2011.
3. Nosrati-Zarenoe R, Hultcrantz E. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss. Part 1: a randomized triple-blind placebo controlled trial. http://mdh.diva-portal.org/smash/record.jsf?pid=diva2:411770.
4. Nosrati-Zarenoe R, Hultcrantz E. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial. Otology & Neurotology 2012;33(4):523-31.
5. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Archives of Otolaryngology 1980;106(12):772-6.
6. Ahn JH, Kim TY, Kim YJ, Han MW, Yoon TH, Chung JW. Lipo-prostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with Type 2 diabetes. Diabetic Medicine 2006;23:1339-43.
7. Ahn JH, Yoo MH, Lee HJ, Chung JW, Yoon TH. Coenzyme Q10 in combination with steroid therapy for treatment of sudden sensorineural hearing loss: a controlled prospective study. Clinical Otolaryngology 2010;35:486-9.
8. Ai W, Tong B, Liu Y, Duan M. Analysis of clinical characteristics and treatment outcome of bilateral and unilateral sudden sensorineural hearing loss. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009;23:307-10.
9. Alexiou Ch, Arnold W, Fauser C, Gloddek B, Fuhrmann S, Lamm K. Influence of glucocorticoids in the treatment of sudden sensorineural hearing loss. Oto-Rhino-Laryngologia Nova 1999;9(3-4):98-104.
10. Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. European Archives of Oto-Rhino-Laryngology 2011;268:1735-41.
11. Angeli SI, Abi-Hachem RN, Vivero RJ, Telischi FT, Machado JJ. L-N-acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss. Acta Oto-Laryngologica 2012;132:369-76.
12. Aoki D, Takegoshi H, Kikuchi S. Evaluation of super-high-dose steroid therapy for sudden sensorineural hearing loss. Otolaryngology - Head & Neck Surgery 2006;134(5):783-7.
13. Arellano B, Garcia Berrocal JR, Gorriz C, Gonzalez FM, Vicente J, Ramirez Camacho R. Treatment protocol for sudden deafness [Protocolo de tratamiento de la sordera subita]. Acta Otorrinolaringologica Espanola 1997;48(7):513-6.
14. Arslan N, Oguz H, Demirci M, Safak MA, Islam A, Kaytez SK, et al. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss. Otology and Neurotology 2011;32:393-7.
15. Asada Y, Suzuki H, Nakabayashi S, Furukawa M. High dose steroid therapy for sudden deafness - efficacy in severe cases. Journal of the Oto-rhino-laryngological Society of Japan 1998;101:1069-74.
16. Bae SC, Noh HI, Jun BC, Jeon EJ, Seo JH, Park SY, et al. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy. Acta Oto-Laryngologica 2013 Jan 28 [Epub ahead of print].
17. Barriat S, van Wijck F, Staecker H, Lefebvre PP. Intratympanic steroid therapy using the Silverstein Microwick for refractory sudden sensorineural hearing loss increases speech intelligibility. Audiology and Neuro-Otology 2012;17:105-11.
18. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otology and Neurotology 2008;29:453-60.
19. Baysal E, Tunç O, Baglam T, Durucu C, Oz A, Karatas ZA, et al. Systemic steroid versus combined systemic and intratympanic steroid treatment for sudden sensorineural hearing loss. Journal of Craniofacial Surgery 2013;24(2):432-4.
20. Behnoud F, Goodarzi MT. The treatment of idiopathic sudden sensorineural hearing loss using phlebotomy: a prospective, randomized, double-blind clinical trial. Acta Medica Iranica 2009;47:439-42.
21. Bianchin G, Russi G, Romano N, Fioravanti P. Treatment with HELP-apheresis in patients suffering from sudden sensorineural hearing loss: a prospective, randomized, controlled study. Laryngoscope 2010;120:800-7.
22. Bittar RS, Oiticica J, Zerati FE, Bento RF. Sudden hearing loss: a ten-year outpatient experience. International Tinnitus Journal 2009;15:196-202.
23. Byl FM. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 1984;94:647-61.
24. Cekin E, Cincik H, Ulubil SA, Gungor A. Effectiveness of hyperbaric oxygen therapy in management of sudden hearing loss. Journal of Laryngology and Otology 2009;123:609-12.
25. Chan A, Tong M, Lee A, Wong E, Abdullah V. A randomized controlled trial on intratympanic steroid treatment for sudden onset sensorineural hearing loss. The Chinese University of Hong Kong 2009 (accessed 9 May 2013).
26. Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otology & Neurotology 2001;22(1):18-23.
27. Chen CY, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otology & Neurotology 2003;24(5):728-33.
28. Chen Y, Wen L, Hu P, Qiu J, Lu L, Qiao L. Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy. Journal of Otolaryngology - Head & Neck Surgery 2010;39:640-5.
29. Chen X, Yu LS, Xia RM. Analysis of the effectiveness in patients who were treated with a course of drugs for sudden deafness which was present for at least three weeks. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2011;46:539-42.
30. Choi SY, Lee YH, Kim YH. Comparison of the efficacy of systemic and combined highly frequent intratympanic steroid treatment on sudden sensorineural hearing loss. Korean Journal of Audiology 2011;15:133-6.
31. Choung YH, Park K, Mo JY, Oh JH, Kim JS. The effects of intratympanic steroid injection for the patients with refractory sudden sensorineural hearing loss. Korean Journal of Otolaryngology - Head and Neck Surgery 2005;48:706-12.
32. Clary M, Murray RC, Loftus P, Dervishaj O, Keith S, Willcox TO, et al. Clinical outcomes in idiopathic sudden sensorineural hearing loss. Laryngoscope 2011;121:S315.
33. Dallan I, De Vito A, Fattori B, Casani AP, Panicucci E, Berrettini S, et al. Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis. Otology & Neurotology 2010;31:25-30.
34. Dallan I, Fortunato S, Casani AP, Panicucci E, Berrettini S, Lenzi R, et al. Intratympanic methylprednisolone as first-line therapy in sudden sensorineural hearing loss: preliminary results from a case-control series. Journal of Laryngology and Otology 2011;125:1004-8.
35. Dauman R, Cros A, Poisot D. Treatment of sudden deafness: first results of a comparative study [Traitements des surdites brusques: premiers resultats d'une etude comparative]. Journal of Otolaryngology 1985;14(1):49-56.
36. Dispenza F, Amodio E, De Stefano A, Gallina S, Marchese D, Mathur N, et al. Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy: a randomized clinical study. European Archives of Oto-Rhino-Laryngology 2011;268:1273-8.
37. Echarri RM, Rivera T, Mate MA, Cobeta I. Sudden hearing loss: effectiveness of a therapeutic protocol [Soddera brusca: eficacia de ub protocolo terapeutico]. Acta Otorrhinolaryngologica Espanola 2000;51(6):490-4.
38. Edamatsu H, Hasegawa M, Oku T, Nigauri T, Kurita N, Watanabe I. Treatment of sudden deafness: carbon dioxide and oxygen inhalation and steroids. Clinical Otolaryngology and Allied Sciences 1985;10(2):69-72.
39. Filipo R, Covelli E, Balsamo G, Attanasio G. Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol. Acta Oto-Laryngologica 2010;130:1209-13.
40. Filipo R, Attanasio G, Viccaro M, Russo FY, Mancini P, Rocco M, et al. Hyperbaric oxygen therapy with short duration intratympanic steroid therapy for sudden hearing loss. Acta Oto-Laryngologica 2012;132:475-81.
41. Fu Y, Zhao H, Zhang T, Chi F. Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: clinical evaluation and laboratory investigation. Auris Nasus Larynx 2011;38:165-71.
42. Fujimura T, Suzuki H, Shiomori T, Udaka T, Mori T. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology 2007;264(8):861-6.
43. Fuse T, Aoyagi M, Funakubo T, Sakakibara A, Yoshida S. Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid. ORL; Journal of Oto-Rhino-Laryngology & its Related Specialties 2002;64(1):6-10.
44. Gianoli G, Li J. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngology - Head and Neck Surgery 2001;125(3):142-6.
45. Gouveris H, Selivanova O, Mann W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. European Archives of Oto-Rhino-Laryngology 2005;262(2):131-4.
46. Gouveris H, Schuler-Schmidt W, Mewes T, Mann W. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss. Otology & Neurotology 2011;32:756-60.
47. Grandis J, Hirsch B, Wagener M. Treatment of idiopathic sudden sensorineural hearing loss. American Journal of Otology 1993;14(2):183-5.
48. Han CS, Park JR, Kim HB, Ahn JK, Park JH, Kang MK, et al. Comparison of the efficacy of systemic and intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Korean Journal of Otorhinolaryngology - Head and Neck Surgery 2008;51:227-33.
49. Han CS, Park JR, Boo SH, Jo JM, Park KW, Lee WY, et al. Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngology - Head and Neck Surgery 2009;141:572-8.
50. Herr BD, Marzo SJ. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngology - Head & Neck Surgery 2005;132(4):527-31.
51. Hong SM, Park CH, Lee JH. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngology - Head and Neck Surgery 2009;141:579-83.
52. Huang T, Chan S, Ho T, Su J, Lee F. Hypaque and steroids in the treatment of sudden sensorineural hearing loss. Clinical Otolaryngology and Allied Sciences 1989;14(1):45-51.
53. Hultcrantz E, Nosrati-Zarenoe R. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss. Part 2: a meta-analysis of a RCT and the Swedish national database. http://liu.diva-portal.org/smash/record.jsf?pid=diva2:411773 (accessed 3 June 2013).
54. Hunchaisri N, Chantapant S, Srinangyam N. Intratympanic dexamethasone for refractory sudden sensorineural hearing loss. Journal of the Medical Association of Thailand 2010;93:1406-14.
55. Joong HA, Mi RK, Hyang CK. Therapeutic effect of lipoprostaglandin E1 on sudden hearing loss. American Journal of Otolaryngology - Head and Neck Medicine and Surgery 2005;26:245-8.
56. Jun HJ, Chang J, Im GJ, Kwon SY, Jung H, Choi J. Analysis of frequency loss as a prognostic factor in idiopathic sensorineural hearing loss. Acta Oto-Laryngologica 2012;132(6):590-6.
57. Kanzaki J, Taiji H, Ogawa K. Evaluation of hearing recovery and efficacy of steroid treatment in sudden deafness. Acta Oto-Laryngologica 1988;456:31-6.
58. Kanzaki J, Inoue Y, Ogawa K, Fukuda S, Fukushima K, Gyo K, et al. Effects of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2003;30:123-7.
59. Kara E, Cetik F, Tarkan O, Suermelioglu O. Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology 2010;267:701-7.
60. Kasapoglu F, Tuzemen G, Hizalan I, Erisen L, Basut O, Onart S, et al. Prognosis in sudden hearing loss: is it the disease or the treatment that determines the prognosis?. Journal of International Advanced Otology 2009;5:187-94.
61. Kawamata T, Ohki S, Sakuma T, Suzaki H. Combination steroid and hyperbaric oxygenation therapy for sudden idiopathic sensorineural hearing loss. Journal of the Oto-Rhino-Laryngological Society of Japan 2007;110(5):395-402.
62. Kim YH, Park KT, Choi BY, Park MH, Lee JH, Oh SH, et al. Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance. European Archives of Oto-Rhino-Laryngology 2011;269(10):2173-8.
63. Kim MG, Jung YG, Eun YG. Effect of steroid, carbogen inhalation, and lipoprostaglandin E(1) combination therapy for sudden sensorineural hearing loss. American Journal of Otolaryngology 2011;32:91-5.
64. Kitajiri S, Tabuchi K, Hiraumi H, Hirose T. Is corticosteroid therapy effective for sudden-onset sensorineural hearing loss at lower frequencies?. Archives of Otolaryngology - Head and Neck Surgery 2002;128(4):365-7.
65. Kitamura K, Doi K, Takeda N, Mishiro Y, Okusa M, Kubo T. Statistical analysis of recovery from sudden deafness among treatment groups. Journal of the Oto-rhino-laryngological Society of Japan 1996;99(11):1676-83.
66. Kopke RD, Hoffer ME, Wester D, O'Leary MJ, Jackson RL. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otology and Neurotology 2001;22(4):475-9.
67. Kubo T, Matsunaga T, Asai H, Kawanoto K, Kusakari J, Nomura Y, et al. Efficacy of defibrinogenation and steroid therapies on sudden deafness. Archives of Otolaryngology - Head and Neck Surgery 1988;114(6):649-52.
68. Lee HS, Kim JM, Kim YJ, Chung DH, Seo BS, Kim SH. Results of intratympanic dexamethasone injection as salvage treatment in idiopathic sudden hearing loss. Journal of Otolaryngology - Head & Neck Surgery 2008;37:263-8.
69. Lee JB, Choi SJ, Park K, Park HY, Choo OS, Choung YH. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology 2011;268:833-9.
70. Leong HK, Loh KK. Prognostic factors in idiopathic sudden hearing loss. Annals Academy of Medicine Singapore 1991;20(5):624-7.
71. Li X, Wang R, Sun LJ, Jiang ZG, Fu ZQ, Guo Y, et al. Study of intratympanic methylprednisolone injections in diabetics with a sudden sensorineural hearing loss. Zhonghua Yi Xue Za Zhi 2010;90:3103-6.
72. Li P, Zeng XL, Ye J, Yang QT, Zhang GH, Li Y. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiology and Neuro-Otology 2011;16:198-202.
73. Lim HJ, Kim YT, Choi SJ, Lee JB, Park HY, Park K, et al. Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial. Otolaryngology - Head and Neck Surgery 2013;148(1):121-7.
74. Liu SC, Kang BH, Lee JC, Lin YS, Huang KL, Liu DW, et al. Comparison of therapeutic results in sudden sensorineural hearing loss with/without additional hyperbaric oxygen therapy: a retrospective review of 465 audiologically controlled cases. Clinical Otolaryngology 2011;36:121-8.
75. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Annals of Otology, Rhinology and Laryngology 1977;86:463-80.
76. Min HJ, Kim JM, Kim K, Park CW, Jeong JH, Lee SH. The combination effects of early intratympanic dexamethasone injection for patients with sudden sensorineural hearing loss. Otolaryngology - Head and Neck Surgery 2011;145:228-9.
77. Minoda R, Masuyama K, Habu K, Yumoto E. Initial steroid hormone dose in the treatment of idiopathic sudden deafness. American Journal of Otology 2000;21(6):819-25.
78. Moon IS, Lee JD, Kim J, Hong SJ, Lee WS. Intratympanic dexamethasone is an effective method as a salvage treatment in refractory sudden hearing loss. Otology and Neurotology 2011;32:1432-6.
79. Mosges R, Koberlein J, Heibges A, Erdtracht B, Klingel R, Lehmacher W. Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. European Archives of Oto-Rhino-Laryngology 2009;266:943-53.
80. Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 1984;94(5):664-6.
81. Nakagawa T, Sakamoto T, Hiraumi H, Kikkawa YS, Yamamoto N, Hamaguchi K, et al. Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial. BMC Medicine 2010;8:76.
82. Nickisch A, Heinemann M, Gross M. Drug therapy in sensorineural hearing loss in childhood [Medikamentose therapie bei schallenmpfindungs-schwerhorigkeiten im kindesalter]. Laryngologie Rhinologie Otologie 1987;66(12):664-6.
83. Nosrati-Zarenoe R, Arlinger S, Hultcrantz E. Idiopathic sudden sensorineural hearing loss: results drawn from the Swedish national database. Acta Oto-Laryngologica 2007;127(11):1168-75.
84. Nosrati-Zarenoe R, Hansson M, Hultcrantz E. Assessment of diagnostic approaches to idiopathic sudden sensorineural hearing loss and their influence on treatment and outcome. Acta Oto-Laryngologica 2010;130:384-91.
85. Ogawa K, Takei S, Inoue Y, Kanzaki J. Effect of prostaglandin E1 on idiopathic sudden sensorineural hearing loss: a double-blinded clinical study. Otology and Neurotology 2002;23:665-8.
86. Orchi K, Mitsui M, Watenabe S, Nakashima H, Ohashi T, Kinoshita H, et al. The effects of high dose steroid therapy on sudden deafness. Journal of the Oto-rhino-laryngological Society of Japan 1998;101:1311-5.
87. Panda NK, Verma RK, Saravanan K. Sudden sensorineural hearing loss: have we got a cure?. Journal of Otolaryngology - Head & Neck Surgery 2008;37:807-12.
88. Park HH, Choi JH, Huh EJ, Lee TH, Nam JK, Kwon JK. Comparison of the effect of high-dose steroid with that of super-high-dose steroid therapy in sudden sensorineural hearing loss. Korean Journal of Otorhinolaryngology - Head and Neck Surgery 2009;52:566-71.
89. Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss. Otolaryngology - Head and Neck Surgery 2011;145:1016-21.
90. Peng Y, Xiong S, Cheng Y, Qi YF, Yang Y. Clinical investigation of different routes of administration of dexamethasone on sudden deafness. Lin chuang er bi yan hou tou jing wai ke za zhi [Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery] 2008;22(10):442-5.
91. Penido NO, Cruz OL, Zanoni A, Inoue DP. Classification and hearing evolution of patients with sudden sensorineural hearing loss. Brazilian Journal of Medical and Biological Research 2009;42:712-6.
92. Plontke SK, Lowenheim H, Mertens J, Engel C, Meisner C, Weidner A, et al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009;119:359-69.
93. Pyykkö I, Ishizaki H, Peltomaa M. Azathioprine with cortisone in treatment of hearing loss in only hearing ear. Acta Oto-Laryngologica 1997;529:83-5.
94. Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 2011;305:2071-9.
95. Roebuck J, Chang CY. Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss. Otolaryngology - Head & Neck Surgery 2006;135(2):276-9.
96. Sakata T, Ueno T, Takase H, Shiraishi K, Nakagawa T. Acute idiopathic sensorineural hearing impairment at frequency exceeding 8 kHz. Acta Oto-laryngologica 2010;130:1141-6.
97. She WD, Dai YH, Du XP, Yu CJ, Chen F, Wang JG, et al. Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss. Otolaryngology - Head and Neck Surgery 2010;142:266-71.
98. Shin SO, Choi YS, Lee JY, Yoo SD. The efficacy of an additional cycle of oral steroids in partially recovered sudden sensorineural hearing loss (SSNHL) after initial oral steroid therapy. Acta Oto-laryngologica. Supplementum 2007;558:49-53.
99. Shiraishi T, Kubo T, Matsunaga T. Chronological study of recovery of sudden deafness treated with defibrinogenation and steroid therapies. Acta Oto-Laryngologica 1991;111(5):867-71.
100. Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngology - Head & Neck Surgery 2005;133(2):251-9.
101. Slattery WH, Fisher LM, Iqbal Z, Liu N. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngology - Head & Neck Surgery 2005;132(1):5-10.
102. Suoqiang Z, Ning Y, Guiliang Z, Yuhua Z, He Q. Effect of retreatment on the end-stage sudden deafness. Cell Biochemistry and Biophysics 2012;62:403-6.
103. Suzuki H, Furukawa M, Kumagai M, Takahashi E, Matsuura K, Katori Y, et al. Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Acta Oto-laryngologica 2003;123:46-50.
104. Suzuki H, Fujimura T, Shiomori T, Ohbuchi T, Kitamura T, Hashida K, et al. Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Auris, Nasus, Larynx 2008;35(2):192-7.
105. Suzuki H, Hashida K, Nguyen KH, Hohchi N, Katoh A, Koizumi H, et al. Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Laryngoscope 2012;122:1154-7.
106. Tsai YJ, Liang JG, Wu WB, Ding YF, Chiang RPY, Wu SM. Intratympanic injection with dexamethasone for sudden sensorineural hearing loss. Journal of Laryngology and Otology 2011;125:133-7.
107. Wang Y-W, Ren J-H, Lu Y-D, Yin T-F, Xie D-H. Evaluation of intratympanic dexamethasone for treatment of refractory sudden sensorineural hearing loss. Journal of Zhejiang University - Science B 2012;13:203-8.
108. Wilkins S, Mattox DE, Lyles A. Evaluation of a shotgun regimen for sudden hearing loss. Otolaryngology - Head and Neck Surgery 1987;97(5):474-80.
109. Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otology & Neurotology 2011;32:774-9.
110. Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngology - Head & Neck Surgery 2006;134(6):940-5.
111. Yang J, Huang L, Shi J, Li Y, Wu H, Kong W. The effect of intratympanic dexamethasone or methylprednisolone on treatment of sudden sensorineural hearing loss. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010;24:594-7.
112. Yang CH, Ko MT, Peng JP, Hwang CF. Zinc in the treatment of idiopathic sudden sensorineural hearing loss. Laryngoscope 2011;121:617-21.
113. Zadeh MH, Storper IS, Spitzer JB. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngology - Head and Neck Surgery 2003;128(1):92-8.
114. Zernotti ME, Paoletti OA, Zernotti M, Martinez ME, Roques-Revol M, Prina AC. Intratympanic dexamethasone as therapeutic option in sudden sensorineural hearing loss. Acta Otorrinolaringologica Espanola 2009;60:99-103.
115. Zhao H, Zhang TY, Fu YY, Jing JH. Preliminary study on intratympanic dexamethasone injection for management of patients with profound sudden hearing loss. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009;44:297-301.
116. Zhou Y, Zheng H, Zhang Q, Campione PA. Early transtympanic steroid injection in patients with 'poor prognosis' idiopathic sensorineural sudden hearing loss. ORL; Journal of Oto-Rhino-Laryngology and Its Related Specialties 2011;73:31-7.
117. Chalmers I, Adams M, Dickersin K, Hetherington J, Tarnow-Mordi W, Meinert C, et al. A cohort study of summary reports of controlled trials. JAMA 1990;263:1401-5.
118. Cole RR, Jahrsdoerfer RA. Sudden hearing loss: an update. American Journal of Otology 1988;9(3):211-5.
119. Eisenman DJ, Alexander A. Effectiveness of treatment for sudden sensorineural hearing loss. Archives of Otolaryngology - Head and Neck Surgery 2000;126:1161-4.
120. Gulya AJ. Sudden sensorineural hearing loss: an otologic emergency. Comprehensive Therapy 1996;22(4):217-21.
121. Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden sensorineural hearing loss. American Journal of Otology 1999;20:587-92; discussion 593-5.
122. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
123. Hughes GB, Freedman MA, Haberkamp TJ, Guay ME. Sudden sensorineural hearing loss. Otolaryngologic Clinics of North America 1996;29(3):394-405.
124. Mattox DE, Lyles CA. Idiopathic sudden sensorineural hearing loss. American Journal of Otology 1989;10(3):242-7.
125. Plontke SK, Meisner C, Caye-Thomasen P, Parnes L, Agrawal S, Mikulec T. Intratympanic glucocorticoids for sudden sensorineural hearing loss. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD008080]
126. Shikowitz MJ. Sudden sensorineural hearing loss. Medical Clinics of North America 1991;75(6):1239-50.
127. Stokroos RJ, Albers FWJ. Therapy of idiopathic sudden sensorineural loss. A review of the literature. Acta Oto-rhino-laryngologica Belgica 1996;50:237-45.
128. Stokroos RJ, Albers FWJ. The etiology of idiopathic sudden sensorineural loss. A review of the literature. Acta Oto-rhino-laryngologica Belgica 1996;50(1):69-76.
129. Thurmond M, Amedee RG. Sudden sensorineural hearing loss: etiologies and treatments. Journal of the Louisiana State Medical Society 1998;150(5):200-3.
130. Wei BPC, Mubiru S, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD003998.pub2]